Genmab Adr (GMAB)

Jun 02, 2025

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire Inc.

Jun 02, 2025

May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025

May 09, 2025

Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX

May 09, 2025

May 09, 2025

Stock Surge: Genmab ADR (GMAB) Closes at 19.42, Marking a -5.73 Increase/Decrease - DWinneX

May 09, 2025

May 09, 2025

Market Momentum Report: Evercore Inc (EVR)’s Positive Close at 216.74 - DWinneX

May 09, 2025

Apr 23, 2025

Investing in Take-Two Interactive Software, Inc (TTWO) Is Getting More Attractive - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

Investing in Genmab ADR (GMAB): What You Must Know - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

Nucor Corp (NUE) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 23, 2025

Apr 17, 2025

EWTX Stock Sees Surge of Approximately 4.24% in Last Five Days - knoxdaily.com

Apr 17, 2025

Apr 16, 2025

GMAB or RGEN: Which Is the Better Value Stock Right Now? - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

Should Value Investors Buy Genmab (GMAB) Stock? - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

Genmab ADR (NASDAQ: GMAB) Jumps 1.19% In Recent Session. Here’s Everything You Need To Know. - Stocksregister

Apr 15, 2025

Apr 10, 2025

AGCO Corp (AGCO) Beta Value: Understanding the Market Risk - News Heater

Apr 10, 2025

Apr 04, 2025

Evercore Inc’s Mixed Bag: Down -29.24% in 6 Months, Down -20.22% in 30 Days - investchronicle.com

Apr 04, 2025

Apr 04, 2025

GMAB’s Debt-to-Equity Ratio at 0.03: What It Means for Genmab ADR’s Future - investchronicle.com

Apr 04, 2025

Apr 03, 2025

CZR Stock Sees Decline of Approximately -4.82% in Last Five Days - knoxdaily.com

Apr 03, 2025

Mar 31, 2025

Magnite Inc (MGNI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Mar 31, 2025

Mar 26, 2025

DLocal Limited (DLO) Shares Decline Despite Market Challenges - The News Heater

Mar 26, 2025

Mar 12, 2025

Genmab ADR Inc. (GMAB) Price Performance: The Role of Supply and Demand - The InvestChronicle

Mar 12, 2025

Feb 07, 2025

Views of Wall Street’s Leading Experts on Genmab ADR - SETE News

Feb 07, 2025

Feb 07, 2025

What is Core & Main Inc (CNM) Stock Return on Shareholders’ Capital? - SETE News

Feb 07, 2025

Feb 07, 2025

There is no doubt that Kite Realty Group Trust (KRG) ticks all the boxes. - SETE News

Feb 07, 2025

Jan 29, 2025

Sea Ltd ADR (NYSE: SE) Jumps 4.64%, Turning Investors Away - Stocks Register

Jan 29, 2025

Jan 29, 2025

Does Genmab ADR (NASDAQ: GMAB) Still Look Hot This Week? - Stocks Register

Jan 29, 2025

Jan 20, 2025

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - MSN

Jan 20, 2025

Jan 17, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN

Jan 17, 2025

Jan 14, 2025

Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance

Jan 14, 2025

Jan 08, 2025

Genmab stock holds Buy rating on positive trial results - Investing.com

Jan 08, 2025

Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024

Nov 11, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 11, 2024

Oct 16, 2024

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024

Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024

Jul 15, 2024

RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com

Jul 15, 2024

Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024

Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024

Mar 01, 2024

GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews

Mar 01, 2024

Sep 05, 2023

Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch

Sep 05, 2023

Apr 13, 2023

Genmab ADR Getting Closer To Key Technical Measure - Investor's Business Daily

Apr 13, 2023

Feb 23, 2023

Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily

Feb 23, 2023

Jan 23, 2023

GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada

Jan 23, 2023

Jan 18, 2023

Ascendis Pharma ADR Scores Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily

Jan 18, 2023

Jan 11, 2023

New Strong Buy Stocks for January 11th - Yahoo Finance

Jan 11, 2023

Dec 12, 2022

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Dec 12, 2022

Dec 02, 2022

Oncolytics Biotech Inc. (ONCY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Dec 02, 2022

Nov 17, 2022

Genmab AS Sponsored ADR (GMAB) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Nov 17, 2022

Oct 21, 2022

4 Biotech Stocks Set to Outpace Q3 Earnings Estimates - Yahoo

Oct 21, 2022

Oct 17, 2022

INCY vs. GMAB: Which Stock Is the Better Value Option? - Yahoo Finance

Oct 17, 2022